{
  "pmcid": "11364141",
  "sha256": "daf037a598b07406b7a35bd3b09a595f0c79aacddf9a88af99f4421b249d0387",
  "timestamp_utc": "2025-11-09T23:15:31.336116+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.532418936446177,
    "reading_ease": 23.47223843493302,
    "word_count": 257
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Neoadjuvant 177 Lu-DOTATATE for NF-PanNETs: A Phase II Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "A sample size of 30 was calculated to test postoperative complication rates against predefined cut-offs."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were adults with sporadic, resectable or potentially resectable NF-PanNETs, positive 68 Ga-DOTA PET, and at least one high-risk feature."
      },
      "Intervention": {
        "score": 2,
        "evidence": "This study aimed to evaluate the safety of neoadjuvant 177 Lu-DOTATATE followed by surgery in high-risk NF-PanNETs."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to evaluate the safety of neoadjuvant 177 Lu-DOTATATE followed by surgery in high-risk NF-PanNETs."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary endpoint was safety, assessed by postoperative morbidity and mortality within 90 days."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 3,
        "evidence": "open-label"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "From March 2020 to February 2023, 31 patients were enrolled"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "26 completed four cycles of 177 Lu-DOTATATE."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Partial radiological response was observed in 18 patients, with stable disease in 13."
      },
      "Harms": {
        "score": 1,
        "evidence": "No postoperative deaths occurred, but complications were noted in 21 patients, with severe complications in seven."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT04385992."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 19,
    "max_score": 25
  }
}